

























	 Isatin‐3‐imine	 derivatives	 (1a‐d)	 have	 been	 synthesized.	 These	 compounds	 were	 thenconverted	 into	 phosphorylated	 products	 2a,	 2c	 with	 triethylphosphite	 and	 3a‐d	 with
triphenylphosphine.	 The	 structures	 of	 the	 new	 compounds	 were	 confirmed	 by	 elemental
analyses,	 IR,	UV/VIS,	 1H	NMR,	 13C	NMR	and	MS	 studies.	The	 structure	 of	 compound	1a	was
also	confirmed	by	single	crystal	X‐ray	diffraction	studies.	Compounds	1b‐d	and	3c‐d	exhibited










The	 chemistry	 of	 isatin	 and	 its	 derivatives	 is	 particularly	
interesting	because	of	their	potential	applications	in	medicinal	
chemistry.	 The	 synthetic	 versatility	 of	 isatin	 has	 led	 to	 the	
extensive	 use	 in	 organic	 synthesis.	 3‐Imino‐2‐amino‐isatins	
were	obtained	by	a	one‐pot	reaction	of	an	excess	of	aniline	(or	
its	 derivatives)	 with	 1,2‐bis(dimethylamino)‐1,2‐dichloro‐
ethene	followed	by	hydrolysis	to	yield	the	corresponding	isatin	
derivatives	 [1].	 The	 construction	 of	 spiroxindole	 via	 imino	
Diels‐Alder	 reaction	 of	 in‐situ	 generated	 isatin	 imine	 with	
dihydropyran	[2].		
Isatins	 are	 known	 to	 exhibit	 variety	 of	 biological	 and	
pharmaceutical	 properties	 [3‐5].	 Schiff	 and	Mannich	 bases	 of	
isatin	 derivatives	 are	 also	 reported	 to	 show	 a	 variety	 of	
biological	activities	[6‐11].	Some	isatin	Schiff	bases	derivatives	
have	been	 synthesized	 and	 realized	 as	 anti‐HTV	 activity	 [12].	
Some	organometallic	Schiff	bases	 containing	Ni(II),	Co(II)	 and	
Cu(II),	 were	 found	 to	 be	 killing	 agents	 for	 Biomphalaria	
Alexandrina	 snails	 without	 affecting	 the	 surrounding	
environment	 [13].	 Other	 synthesized	 Schiff	 bases	 from	 the	
reaction	of	isatin	with	primary	aromatic	amines	were	randomly	
screened	 for	 their	 in	 vitro	 anti‐leishmanial	 potential	 [14].	 1‐
(Substituted	 phenylaminomethyl)‐3‐(coumarin‐3‐yl‐
carbohydrazine)	 isatins	 were	 synthesized	 and	 exhibited	
potential	 anti‐covulsants	 [15].	 The	 isatin	 core	 structure	 was	
found	 to	 be	 a	 novel	 chemical	 scaffold	 in	 trans‐thyretin	
fibrillogenesis	inhibitor	design	[16].		
Organophosphorus	 derivatives	 containing	 isatin‐3‐
hydrazones	 were	 detected	 as	 chemotherapeutants	 against	
fungal	pathogens	of	 sugarcane	 [17].	 Isatin	derivatives	bearing	
1,2,4‐triazole	ring	were	also	synthesized	[18],	where	N‐bridged	
heterocyclic	 derivatives	 derived	 from	 1,2,4‐triazoles	 showed	
varied	 biological	 activities	 such	 as:	 antimicrobial	 [19],	
anticonvulsant	 [20],	 anticancer	 [21],	 analgesic	 [22],	 anti‐HIV	
[23],	 and	 anti‐inflammatory	 [24].	 These	 biological	 and	 the	











FT‐IR	 spectra	 were	 recorded	 on	 Mattson	 1000	
spectrophotometer,	 Microanalytical	 Center,	 Cairo	 University,	
Giza.		
UV/Vis	 spectra	 were	 recorded	 using	 Shimadzu	 UV	 1601	
Spectrophotometer.		
Mass	 spectra	 were	 measured	 on	 GCMS‐QP	 1000	 EX	 Gas	
Chromatography‐Mass	spectrometer,	Cairo	University,	Giza	and	
on	 Gas	 chromatography‐Mass	 spectrometer	 in	 National	
Research	Center,	Egypt.		
1H	 NMR	 spectra	 were	 recorded	 on	 Gemini	 200,	
spectrometer	 in	 DMSO‐d6	 solution	 with	 TMS	 as	 internal	
standard	in	Cairo	University,	Giza.		
X‐ray	 single	 crystal	 diffraction	 studies	were	 performed	 in	
National	Research	Center,	Egypt.	A	suitable	crystal	(size	0.50		
0.50	 	 0.10	 mm)	 was	 selected	 from	 batch	 of	 crystals	 of	
compound	 1a	 obtained	 by	 crystallization	 from	 alcohol.	 All	
diagrams	 and	 calculations	 were	 performed	 using	 maxus	
(Bruker	 Nonius,	 Delft	 &	 MacScience,	 Japan),	 using	 graphite	
monochromated	MoK	radiation	(=0.71073	Å).		



















A	 mixture	 of	 (0.001	 mol,	 0.146	 g)	 of	 isatin	 and	 amine	
derivatives	 namely	 2,6‐diisopropylaniline,	 4‐aminosalicylic	
acid,	 4‐aminodiphenylamine	 and	 4‐amino‐N‐[5‐methoxy‐2‐
pyrimidinyl]	 benzene	 sulphonamide	 in	 ethyl	 alcohol	 (20	mL)	
was	refluxed	 for	3h.	The	reaction	mixture	was	cooled	and	the	




(KBr,	 max,	 cm‐1):	 3163	 (N‐H),	 2962‐2866	 (C‐H	 aliph.),	 1733	







oC.	 IR	 (KBr,	 max,	 cm‐1):	 3163	 (N‐H),	 2962‐2866	 (C‐H	 aliph.),	
1733	 (C=O),	 1683	 (C=N).	 UV/Vis	 (max	 (nm),	 	 (L/mol.cm)):	
260,	7.2x103;	298,	9.6x103;	314,	10.5x103;	415,	1.8x103.	1H	NMR	
(DMSO‐d6,	δ,	ppm):	11.2	(s,	1H,	COOH),	8.3	(s,	1H,	NH),	8.0‐6.9	
(m,	7H,	Arom.),	 4.9	 (s,	 1H,	OH).	Anal.	 calcd.	 for	C15H10N2O4:	 C,	
63.82;	H,	3.54;	N,	9.92.	Found:	C,	63.74;	H,	3.71;	N,	10.24%.	
(Z)‐3‐((4‐(phenylamino)phenyl)imino)indolin‐2‐one	 (1c):	
Black	crystals	 from	ethanol	 in	93%	yield.	M.p.:	213‐214	oC.	 IR	
(KBr,	 max,	 cm‐1):	 3163	 (N‐H),	 2962‐2866	 (C‐H	 aliph.),	 1733	
(C=O),	 1663	 (C=N).	 UV/Vis	 (max	 (nm),	 	 (L/mol.cm)):	 487,	
17.15x103,	325,	20.07x103.	 1H	NMR	(DMSO‐d6,	δ,	ppm):	8.2	(s,	




ylidene)amino)benzenesulfon	 amide	 (1d):	 Orange	 crystals	
from	ethanol	in	64%	yield.	M.p.:	188‐189	oC.	IR	(KBr,	max,	cm‐









(2,	 6‐diisopropoylphenyl‐imino)indolin‐2‐one	 (1a)	 or	 3‐(4‐
(phenylamino)phenyl‐imino)indolin‐2‐one	 (1c)	 in	 10	mL	 THF	
was	stirred	for	3	hours	at	room	temperature,	then	left	to	stand	
overnight.	 The	 resulting	 precipitate	 was	 filtered	 and	
crystallized	 from	petroleum	ether	 (40‐60	oC).	 It	gave	one	spot	
on	(TLC)	(Scheme	2).	











































































imine	 derivatives	 namely	 (2,	 6‐diisopropoylphenyl‐
imino)indolin‐2‐one	(1a),	2‐hydroxy‐4‐(2‐oxoindoylidene‐








[25].	 UV/Vis	 (max	 (nm),	 	 (L/mol.cm)):	 403,	 4.65x103;	 294,	
10.5x103.	1H	NMR	(DMSO,	δ,	ppm):	11.01	(s,	H,	NH),	7.62‐6.70	
(m,	 22H,	 Arom.),	 2.67	 (m,	 2H,	 2CH),	 1.09	 (d,	 12H,	 4CH3).	 13C	
NMR	(DMSO,	δ,	ppm):	163	(C=O),	155.9‐111.5	(Arom.),	40.33‐
22.82	(Aliphatic).	MS	(m/z,	%):	874	(M+,	0.01),	568	(0.05),	306	






(max	 (nm),	 	 (L/mol.cm)):	 254,	 8.4x103;	 298,	 10.06x103;	 315,	




Compound	 3c:	 Black	 crystals	 from	 THF	 in	 81.48%	 yield,	




(96),	 283	 (C15H14N3OP+,	 100),	 277	 (6),	 179	 (34),	 164	 (50),	 77	
(13),	 51(4).	 Anal.	 calcd.	 for	 C38H30N3OP:	 C,	 79.30;	 H,	 5.21;	 N,	
7.30.		Found:	C,	79.20;	H,	5.40;	N,	7.25%.	




25H,	 Arom.),	 4.00	 (s,	 1H,	 SO2NH),	 3.77	 (s,	 3H,	 CH3).	 13C	 NMR	
(DMSO,	 δ,	 ppm):	 153	 (C=O),	 151	 (‐S‐NH‐C),	 150	 (‐N‐C),	 149	
(benzene‐C‐NH),	 144	 (pyrimidine‐C‐O);	 138‐128	 (triphenyl	
phosphine),	 125‐112	 (indolyl),	 109	 ((indolyl)	 C‐P),	 56	
((aliphatic)	 C‐O).	MS	 (m/z,	%):	 479	 (1.22),	 279	 (9),	 278	 (32),	
277	 (100),	262	 (14),	 201	 (11),	 147	 (2),	 118	 (4),	 77	 (6).	Anal.	





A	 filter	 paper	 sterilized	 disc	 saturated	 with	 measured	
quantity	 of	 the	 sample	 is	 placed	 on	 plate	 containing	 solid	
bacterial	 medium	 (nutrient	 agar	 broth)	 or	 fungal	 medium	
(Doxs	medium)	which	has	been	heavily	seeded	with	the	spore	
suspension	 of	 the	 tested	 organism.	 After	 inoculation,	 the	
diameter	of	the	clear	zone	of	inhibition	surrounding	the	sample	








acid,	 4‐aminodiphenylamine	 and	 4‐amino‐N‐[5‐methoxy‐2‐
pyrimidinyl]	 benzene	 sulphonamide	 in	 ethyl	 alcohol	 under	
reflux	to	afford	3‐imine	derivatives;	3‐(2,6‐diisopropoylphenyl	
imino)indolin‐2‐one	(1a),	2‐hydroxy‐4‐(2‐oxoindolin‐3‐ylidene	
amino)benzoic	 acid	 (1b),	 3‐(4‐(phenylamino)phenyl‐	 imino)	
indolin‐2‐one	 (1c)	 and	N‐(5‐methoxypyrimidin‐2‐yl)‐4‐(2oxo‐
indolin‐3‐ylideneamino)‐benzenesulphonamide	 (1d).	 The	
structures	 of	 these	 compounds	were	 confirmed	 by	 elemental	





1.	 X‐ray	 single	 crystal	 diffraction	 data	 for	 compound	 1a:	
C20H22N2O;	 tetragonal;	 141/a;	 unit	 cell	 dimensions																										
a	 =	 28.8600(9)	 Å,	 b	 =	 28.8600(9)	 Å,	 c	 =	 8.7587(5)	 Å;																						
V	=	7295.1(5)	Å3;	Z	=	16;	Dx	=	1.116	Mg	m‐3;	1721	independent	
reflections;	 max	 =	 19.57	 °;	 1158	 observed	 reflections.	
Refinement	method	was	 full	matrix	 least	 squares	 refinement,	
R(all)=	0.087,	R(gr)=0.063,	wR(ref)=0.128;	wR(all)=0.130.	
wR(gt)=0.128,	 (ref)	 =	 4.068,	 S(all)	 =	 3.632,	 S(gt)	 =	 4.067.	
Selected	geometrical	parameters	are	given	in	Table	1.	
3‐(2,6‐diisopropoylphenylimino)indolin‐2‐one	(1a)	reacted	
with	 triethyl	 phosphite	 and	 triphenylphosphine	 in	
tetrahydrofuran	 to	 afford	 two	 new	 compounds	 2a	 and	 3a	
containing	five‐membered	hetero	ring	similar	to	dimeric	spiro	
phospholanes	 [30‐33].	 The	 two	 suggested	 structures	 were	




showed	 two	C=O	 at	1758	and	1734	 cm‐1	 and	P‐O‐alkyl	 at	 1032	
cm‐1	 for	2a,	 while	 for	 compound	 3a,	 it	 showed	P‐Ph	 at	 1432					
cm‐1	[25].	Comparing	the	1H‐NMR	spectra	of	compounds	2a	and	
3a,	 the	spectrum	of	3a	 showed	fifteen	aromatic	protons	extra	
than	 the	 aromatic	 protons	 in	 2a	 due	 to	 triphenylphosphinyl	
protons,	also	the	spectrum	of	2a	showed	signals	at	δ	4	ppm	and	
1.2	 ppm	 due	 to	 aliphatic	 protons.	 The	 13C	 NMR	 spectrum	 of	





















Triphenylphosphine	 reacted	 with	 2‐hydroxy‐4‐(2‐
oxoindol in‐3‐y l ideneamino) 	 benzo ic 	 ac id 	 (1b) 	 in 	





one	 (1c)	 with	 triethylphosphite	 and	 triphenylphosphine	
yielded	 compounds	 2c	 and	 3c,	 respectively,	 	 with	 three‐
membered	hetero	rings.		
The	 reaction	 of	 N‐(5‐methoxypyrimidin‐2‐yl)‐4‐(2oxo‐
indolin‐3‐ylideneamino)‐benzenesulphonamide	 (1d)	 with	
triphenylphosphine	 yielded	 compound	 3d	 with	 three	
membered	hetero	ring.	 IR	spectrum	showed	a	new	absorption	
band	at	1431	cm‐1	due	to	P‐Ph.	The	presence	of	C=O	(NH‐CO)	at	
1727	 cm‐1	 confirmed	 the	 three	 membered	 heterophosphorus	






microbial	 activity	 against	Bacillus	 subtilis	 (G+)	 and	Escherichia	
Coli	 (G‐).	 Control	 experiment	 was	 carried	 out	 under	 similar	
condition	by	using	tetracycline	as	standard.	The	inhibition	zone	
measure	 in	mm	showed	 that	 compounds	1a,	2a	 and	3a	were	
inactive	 towards	 bacteria.	 The	 antifungal	 activity	 was	 tested	
against	 the	 fungal	 species	 Aspergillus	 flavus	 and	 Candida	
albicans	at	100	µg	concentration.	Amphotericin	B	was	used	as	
standard	 under	 the	 same	 condition.	 The	 antifungal	 data	















1a 0 0 0	 0
1b 14 14 0	 0
1c 13 14 0	 0
1d 15 13 0	 0
2a 0 0 0	 0
3a	 0	 0	 13	 13	
3c 14 14 0	 0
3d	 16	 15	 0	 0	
Tetracycline	 32	 35	 0	 0	






via	 www.ccdc.cam.ac.uk/data_request/cif	 or	 by	 e‐mailing	
data_request@ccdc.cam.ac.uk,	or	by	contacting	The	Cambridge	
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